Adamis Pharmaceuticals Corporation

ADMP | NASDAQ | 1 Sledující

$0.78

0.85%

$0.78

Sledovat

Overview Metrics Financials

Company Quality

Profitability Score

23/100

Solvency Score

25/100

Dividends

Dividends data currently unavailable.

Earnings

Earnings data currently unavailable.

My Notes

You haven't added any notes for this stock yet. Use this space to record your insights or strategies.

Profile

Healthcare

Sektor

Drug Manufacturers - Specialty & Generic

Průmysl

Dr. Ebrahim Versi M.D., Ph.D.

CEO

Zaměstnanci

San Diego

Centrála

Země

Key Metrics TTM

Valuation

Market cap.

$7.3M

Enterprise Value

-$6.6B

Price to Earnings

-0.67

Price to Sales

0.80

Price to Book

-0.0011

Price to Cash Flow

-2.82

Profitability

Return on Assets

-0.09%

Return on Equity

0.33%

Return on Invested Capital

0.39%

Gross Margin

96.02%

Operating Margin

-160.65%

Net Margin

-90.70%

Liquidity

Quick Ratio

0.54

Current Ratio

0.58

Cash Ratio

0.50

Inventory Turnover

0.0005

Asset Turnover

0.0010

Total Liabilities

$14B

Solvency

Debt to Assets

0.0071

Debt to Equity

N/A

Interest Coverage

-864.8

Equity Ratio

-0.55

Long-term Debt to Cap.

0.00

Altman Z-Score

-51.31

Performance

Performance data currently unavailable.

Earnings Waterfall

Debt level and coverage

Debt level and coverage data currently unavailable.

Earnings

Feed

There are no posts to show right now.